ACUPA |
((S)-2-(3-((S)-5-amino-1- carboxypentyl) ureido) pentanedioic acid |
BNCT |
boron neutron capture therapy |
BSB |
binding site barrier |
Chk |
choline kinase |
DFB |
deferoxamine B |
DUPA |
2-[3-(1,3-dicarboxypropyl)-ureido]pentanedioic acid |
EPR |
enhanced permeability and retention |
FDA |
Food and Drug Administration |
GCPII |
glutamate carboxypeptidase II |
GRPR |
gastrin-releasing peptide receptors |
NPs |
nanoparticles |
PCa |
prostate cancer |
PEI |
polyethyleneimine |
PEG |
polyethylene glycol |
PET |
positron emission tomography |
PLA |
polylactic acid |
PLGA |
poly(D,L-lactide-co-glycolide) |
PSMA |
prostate specific membrane antigen |
SPECT |
single-photon emission computerized tomography |
TFA |
trifluoroacetic acid |